Evidence map›Paper›PMID 29194107›Full record

ArticleInternational journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists2018

Vestibulovaginal Sclerosis Versus Lichen Sclerosus.

Tania Day, Kate Burston, Graeme Dennerstein, Ross Pagano, James Scurry

Abstract read
In one paragraph

Article in International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Vestibulovaginal Sclerosis in a Transgender Man on Testosterone.Journal of lower genital tract disease · 2020
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tania DayDepartment of Maternity and Gynecology, John Hunter Hospital (T.D., K.B.) Faculty of Health and Medicine, University of Newcastle (T.D., J.S.) Anatomical Pathology, Pathology North, Hunter New England (J.S.), Newcastle, NSW Dermogynaecology Clinic, Mercy Hospital for Women, Heidelberg (G.D.) Vulvar Disorders and Dermatology Clinic, Royal Women's Hospital, Melbourne (R.P.), Vic., Australia.
Kate Burston
Graeme Dennerstein
Ross Pagano
James Scurry

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To determine if vestibulovaginal sclerosis and lichen sclerosus (LS) are 2 distinct entities. Biopsies obtained from the vagina or vulvar vestibule that contained abnormal subepithelial collagen were reviewed. Cases were categorized either as LS or vestibulovaginal sclerosis based on presence or absence of basal layer degeneration and lymphocytic infiltrate. Clinical data collected included examination findings, biopsy site and indication, previous vulvovaginal surgery, medications at time of biopsy, vulvar LS, treatment, and response. There were 15 cases with a mean age of 62 yr (range: 32-86 yr); 12 (80%) specimens were from vestibule and 3 from vagina. Nine cases were categorized as LS because of lymphocytic infiltrate in combination with basal layer degeneration, of these 8 had LS elsewhere on vulvar skin. Six cases were classified as vestibulovaginal sclerosis and had an absent or sparse lymphocytic infiltrate and essentially normal epithelium; none of these had vulvar LS. While vestibulovaginal sclerosis and lichen sclerosus are distinguishable clinically and histopathologically, further studies are needed to determine if vestibulovaginal sclerosis is a subset of LS or a different condition.

Indexed as

AdultAgedAged, 80 and overCollagenFemaleHumansMiddle AgedSclerosisVaginaVaginal DiseasesVulvaVulvar Lichen SclerosusCollagen

Identifiers

PMID29194107
PMCPMC6012045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.